Pharma channel feed

White House bud­get re­quest would cut bil­lions at NIH and CDC, add $500M for MA­HA

Last month
FDA+

FDA with­draws two fi­nal guid­ances, pulls com­pli­ance dead­lines for bone al­lo­graft mak­ers

Last month
R&D
FDA+

Miss­ing REMS de­lays Cy­to­ki­net­ic­s' heart drug PDU­FA, stock drops

Last month
FDA+

HHS launch­es $500M uni­ver­sal vac­cine plat­form as RFK Jr. shakes up US vac­cine pol­i­cy

Last month
Coronavirus

Am­gen says FDA hold is lift­ed on its Phase 1 obe­si­ty can­di­date as Mar­i­Tide en­ters Phase 3

Last month

FDA ad­comms slat­ed to re­view da­ta on long-term opi­oid use, over­dos­es

Last month
FDA+

Lil­ly CEO Ricks urges Trump to drop drug tar­iff plan

Last month
Manufacturing

Mod­er­na, fac­ing rev­enue miss­es and po­lit­i­cal head­winds, dis­ap­points Wall Street

Last month
R&D

US drug­mak­ers in­creas­ing­ly look abroad for clin­i­cal tri­als as con­fi­dence in FDA wa­vers

Last month
In Focus

FDA ap­proves Sat­suma's mi­graine nasal spray af­ter re­jec­tion in 2024

Last month
FDA+

Bio­gen says Leqem­bi sales are im­prov­ing slow­ly fol­low­ing lack­lus­ter launch

Last month

Lil­ly meets sales ex­pec­ta­tions, but No­vo gains on PBM win

Last month

Am­i­cus grabs Dimer­ix’s rare kid­ney dis­ease drug for $30M up­front

Last month
Deals

Mod­er­na ex­pands ef­fort to rein in costs in an ‘un­cer­tain en­vi­ron­ment’

Last month
R&D

BeiGene scores a win from US Patent Of­fice in spat over Brukin­sa

Last month
Law

Re­gen­eron los­es bid to fend off DOJ fight over Eylea Medicare pay­ments

Last month
Law

FDA ap­proves J&J's rare dis­ease drug that's ex­pect­ed to com­pete with ar­genx and UCB

Last month
FDA+

Up­dat­ed: No­var­tis to buy Reg­u­lus Ther­a­peu­tics for up to $1.7B

Last month
Deals

GSK's sup­ply chain 're­set' af­ter Ha­le­on spin­off to ease tar­iff im­pact, CEO says

Last month
Manufacturing

Bridge­Bio’s At­tru­by out­per­forms sales ex­pec­ta­tions, shares rise

Last month

Pfiz­er CEO Bourla sug­gests phar­ma tar­iffs will fo­cus on US ad­ver­saries, not al­lies

Last month
China

Join us at 12 p.m. ET: How phar­ma is re­act­ing to ‘Lib­er­a­tion Day’

Last month
Editor's note

FDA ap­proves Abeona’s skin dis­ease cell ther­a­py

Last month
Cell/Gene Tx
FDA+

With a new CEO, oligonu­cleotide biotech Crey­on forges Eli Lil­ly part­ner­ship

Last month
Financing
Startups
First page Previous page 45678910 Next page Last page
A service from the Financial Times